What is it about?
Pulmonary toxicity should be considered in any patient on sirolimus with respiratory symptoms and opacities on chest imaging. The role of fluorodeoxyglucose positron emission tomogram scan in evaluation of sirolimus-induced lung toxicity has not been previously described, and this is the first report of this type of scan finding indicating intense inflammation in this condition.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
FDG-PET has not been used before as diagnostic tool in Sirolimus lung toxicity
Perspectives
Role of Fluorodeoxyglucose Positron Emission Tomogram Scan in Sirolimus-Induced Lung Toxicity: A Rare Case Report
Dr Sarfraz Saleemi
King Faisal Specialist Hospital and Research Center
Read the Original
This page is a summary of: Role of Fluorodeoxyglucose Positron Emission Tomogram Scan in Sirolimus-Induced Lung Toxicity: A Rare Case Report, Experimental and Clinical Transplantation, December 2020, Baskent University,
DOI: 10.6002/ect.2020.0306.
You can read the full text:
Contributors
The following have contributed to this page
